- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Refractory Castration-resistant Prostate Cancer
Total 91884 results
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Angle plcMidLantic Urology, LLCTerminatedProstate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate CarcinomaUnited States
-
Klus Pharma Inc.CompletedCervical Cancer | Head and Neck Cancer | Mucoepidermoid Carcinoma | Pancreatic Cancer | Recurrent Prostate Cancer | Lung Cancer | Rectal Cancer | Solid Tumor | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Recurrent Ovarian Carcinoma | Bladder Cancer | Skin Cancer | HER2-positive Breast Cancer | Rare Diseases | Colo-rectal Cancer and other conditionsUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityCompletedCastration-resistant Prostate CancerChina
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedFatigue | Anemia | Prostate CancerUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...Active, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Circulating Tumor CellsItaly
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
David M LubaroffUnited States Department of DefenseCompletedHormone Refractory Prostate CancerUnited States
-
BayerCompletedBone Metastases | Hormone Refractory Prostate Cancer
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
Shaare Zedek Medical CenterCompletedGaucher Disease, Type 1Israel
-
University Hospital, GhentCompletedProstatic Neoplasms | Physical Activity | Exercise | Castration-resistant Prostate CancerBelgium
-
Rigshospitalet, DenmarkCompletedCastration-resistant Prostate CancerDenmark
-
Biosplice Therapeutics, Inc.Active, not recruitingColorectal Cancer | Non-small Cell Lung Cancer | Castration-resistant Prostate CancerUnited States, Australia
-
Massachusetts General HospitalBayerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer Metastatic to BoneUnited States
-
Mayo ClinicCompleted
-
GB006, Inc., a wholly owned subsidiary of Gossamer...Merck Sharp & Dohme LLCTerminatedRenal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal... and other conditionsUnited States, United Kingdom
-
Hospital Sirio-LibanesHospital Moinhos de VentoCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Universitätsklinikum Hamburg-EppendorfBoehringer IngelheimTerminated
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, IncActive, not recruitingProgressive Disease | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Adenocarcinoma | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation... and other conditionsUnited States
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsCompletedProstate Cancer MetastaticNetherlands
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
UNICANCERInstitut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...CompletedChemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor CellsFrance
-
MacroGenicsCompletedMelanoma | Renal Cell Carcinoma | Head and Neck Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Triple-negative Breast CancerUnited States
-
Asan Medical CenterDong-A PharmaceuticalCompletedProstatic NeoplasmsKorea, Republic of
-
Dana-Farber Cancer InstituteSanofiCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma IncCompletedCastration-resistant Prostate CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
Johns Hopkins UniversityGilead SciencesCompleted
-
BayerCompletedCastration-Resistant Prostatic CancerGermany
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompletedCastration-resistant Prostate CancerNetherlands
-
CelgeneCompletedNeoplasm Metastasis | Prostate Cancer | Chronic Lymphocytic Leukemia | Glioblastoma Multiforme | Squamous Cell Carcinoma of Head and Neck | Ewing's OsteosarcomaUnited States, Spain, France, Germany
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
Centre Francois BaclesseGIRCI (French Interregional Group of Clinical Research and Innovation); Ligue...TerminatedMetastasis | Castration-resistant Prostate CancerFrance
-
UNC Lineberger Comprehensive Cancer CenterWake Forest University Health SciencesCompletedCastration-resistant Prostate Cancer | Androgen Deprivation TherapyUnited States
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Korean Cancer Study GroupCompletedHormone Refractory Prostate CancerKorea, Republic of